Home > News By Company > RNCOS
Healthcare Reform to Accelerate Chinese Pharma Market
Pharmaceutical market in China is projected to grow at a CAGR of over 18% during 2010-2012, driven by increasing prevalence of diseases and increasing penetration of health insurance.
(EMAILWIRE.COM, November 04, 2009 ) New Delhi, India - China is one of the top ten pharmaceutical markets in the world. The strong demand in Chinese pharmaceutical is mainly driven by a large population base, increasing penetration of health insurance alongwith some other factors. The popularity of western drugs among Chinese population has increased over the last few years because of their higher efficacy than traditional Chinese medicines. Backed by all these factors, pharmaceutical market in China is projected to grow at a CAGR of around 18% during 2010-2012, says our new analytical study on the sector called “China Healthcare Sector Analysis”.
We have done extensive research on China’s healthcare market in order to identify various developments and trends undergoing across the market. According to our study, public sector funding is the major source of financing in the country’s healthcare sector. However, government is now also promoting investments by private sector units. The major reasons behind the growth of healthcare industry are growing aging population, healthcare reform in rural areas by the government and large population base of the country.
Our report has found that Chinese western drugs market is dominated by generics segment due to weak intellectual property protection in the country. According to our industry experts, several steps should be taken by the government to improve protection of intellectual property. Earlier, the pharma market was dominated by traditional Chinese medicine but now industry scenario has changed and western drugs are leading the market. In this regard, this report provides rational analysis of the market taking various macro and micro economic factors into consideration.
Our study also analyzes various emerging market trends like telemedicine, health insurance market, etc. It studies key segments of the industry to give a brief account on the future scenario of the industry, including forecast on various industry segments. It also discusses various factors that are fueling the growth of China’s healthcare sector.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM121.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
We have done extensive research on China’s healthcare market in order to identify various developments and trends undergoing across the market. According to our study, public sector funding is the major source of financing in the country’s healthcare sector. However, government is now also promoting investments by private sector units. The major reasons behind the growth of healthcare industry are growing aging population, healthcare reform in rural areas by the government and large population base of the country.
Our report has found that Chinese western drugs market is dominated by generics segment due to weak intellectual property protection in the country. According to our industry experts, several steps should be taken by the government to improve protection of intellectual property. Earlier, the pharma market was dominated by traditional Chinese medicine but now industry scenario has changed and western drugs are leading the market. In this regard, this report provides rational analysis of the market taking various macro and micro economic factors into consideration.
Our study also analyzes various emerging market trends like telemedicine, health insurance market, etc. It studies key segments of the industry to give a brief account on the future scenario of the industry, including forecast on various industry segments. It also discusses various factors that are fueling the growth of China’s healthcare sector.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM121.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |